Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
boston top stories
deals
fda
2
×
life sciences
national blog main
national top stories
2
×
new york blog main
achromatopsia
beta-thalassemia
bill cassidy
biotech
bluebird bio
boston
cancer
cancer immunotherapy
center for medicare and medicaid services
clinical trials
companion diagnostic
daniel o'day
dna
foundation medicine
foundationone cdx
foundationone heme
gene therapy
genentech
harvard pilgrim health care
hemophilia
johnson & johnson
luxturna
mark warner
mathai mammen
medicaid
meiragtx
new york
new york top stories
novartis
osimertinib
patient affordability value and efficiency act
roche
What
morning
2
×
acquire
age
agreed
big
bigger
biggest
billion
broad
come
confidence
deal
didn’t
emerging
foundation
gain
gave
gene
genentech
j
johnson
medicine
meiragtx
momentum
panels
past
pay
pays
picked
profiling
recently
redux
remaining
rest
roche
share
signal
signals
stock
struggled
Language
Current search:
fda
×
morning
×
" national top stories "
×
@xconomy.com
5 years ago
With $100M MeiraGTx Deal, J&J Signals Bigger Move Into Gene Therapy
@xconomy.com
5 years ago
In a Genentech Redux, Roche Pays $2.4B for Rest of Foundation Medicine